Skip to main content
. 2013 Nov 22;3(11):e162. doi: 10.1038/bcj.2013.58

Figure 4.

Figure 4

TTP (a) according to the number of previous therapies, (b) previous treatment with alkylating, (c) previous treatment with IMIDs, (d) refractoriness to lenalidomide, (e) previous treatment with bortezomib and (f) previous treatment with bortezomib and lenalidomide.